New program aims to smooth tough transition for teens with eating disorders

NCT ID NCT07518641

Not yet recruiting Knowledge-focused Sponsor: McMaster University Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study tests a structured program called TransitionED designed to help youth aged 16+ with eating disorders move from pediatric to adult healthcare. The program includes planning packages, guided meetings, and a personal profile to share with new providers. Researchers will check if the program is practical and acceptable in real hospital settings, involving 60 youth, their caregivers, and clinicians.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: TransitionED Healthcare Transition Framework (behavioural intervention)
What this could lead to: If successful, this could provide a practical, evidence-based model to improve care transitions for youth with eating disorders, reducing gaps in treatment.
What could go wrong: This is a small feasibility study (60 participants) with no control group, so it cannot prove the program improves health outcomes. Results may not apply to all settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for EATING DISORDERS IN ADOLESCENCE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

eating disorder Feeding and Eating Disorders

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

EATING DISORDERS IN ADOLESCENCE TRANSITION OF CARE

Contacts and locations

Locations

McMaster University

Hamilton, Ontario, L8N3Z5, Canada
University of Calgary

Calgary, Alberta, T2N 1N4, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.